725
Views
7
CrossRef citations to date
0
Altmetric
Research Paper

Structural studies on Laz, a promiscuous anticancer Neisserial protein

, , , &
Pages 141-148 | Received 15 Jan 2015, Accepted 19 Feb 2015, Published online: 15 Apr 2015

References

  • Lancaster KM, Farver O, Wherland S, Crane EJ, Richards JH, Pecht I, Gray HB. Electron transfer reactivity of type zero Pseudomonas aeruginosa azurin. J Am Chem Soc 2011; 133: 4865-73; PMID:21405124; http://dx.doi.org/10.1021/ja1093919
  • Savelieff MG, Lu Y. Cu(A) centers and their biosynthetic models in azurin. J Biol Inorg Chem 2010; 15: 461-83; PMID:20169379; http://dx.doi.org/10.1007/s00775-010-0625-2
  • Mahfouz M, Hashimoto W, Das Gupta TK, Chakrabarty AM. Bacterial proteins and CpG-rich extrachromosomal DNA in potential cancer therapy. Plasmid 2007; 57:4-17; PMID:17166586; http://dx.doi.org/10.1016/j.plasmid.2006.11.001
  • Punj V, Bhattacharyya S, Saint-Dic D, Vasu C, Cunningham EA, Graves J, Yamada T, Constantinou AI, Christov K, White B, et al. Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer. Oncogene 2004; 23: 2367-78; PMID:14981543; http://dx.doi.org/10.1038/sj.onc.1207376
  • Yamada T, Goto M, Punj V, Zaborina O, Kimbara K, Das Gupta TK, Chakrabarty AM. The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53. Infect Immun 2002; 70: 7054-62; PMID:12438386; http://dx.doi.org/10.1128/IAI.70.12.7054-7062.2002
  • Hiraoka Y, Yamada T, Goto M, Das Gupta TK, Chakrabarty AM. Modulation of mammalian cell growth and death by prokaryotic and eukaryotic cytochrome c. Proc Natl Acad Sci USA 2004; 101:6427-32; PMID:15082831; http://dx.doi.org/10.1073/pnas.0401631101
  • Yamada T, Hiraoka Y, Ikehata M, Kimbara K, Avner BS, Das Gupta TK, Chakrabarty AM. Apoptosis or growth arrest: modulation of tumor suppressor p53s specificity by bacterial redox protein azurin. Proc Natl Acad Sci USA 2004; 101: 4770-5; PMID:15044691; http://dx.doi.org/10.1073/pnas.0400899101
  • Fialho AM, Stevens FJ, Das Gupta TK, Chakrabarty AM. Beyond host-pathogen interactions: microbial defense strategy in the host environment. Curr Opin Biotechnol 2007; 18:279-86; PMID:17451932; http://dx.doi.org/10.1016/j.copbio.2007.04.001
  • Chakrabarty AM, Bernardes N, Fialho AM. Bacterial proteins and peptides in cancer therapy: today and tomorrow. Bioengineered 2014; 5: 234-42; PMID:24875003; http://dx.doi.org/10.4161/bioe.29266
  • Arvidsson RH, Nordling M, Lundberg LG. The azurin gene from Pseudomonas aeruginosa. cloning and characterization. Eur J Biochem 1989; 179: 195-200; PMID:2537198; http://dx.doi.org/10.1111/j.1432-1033.1989.tb14540.x
  • Goto M, Yamada T, Kimbara K, Horner J, Newcomb M, Das Gupta TK, Chakrabarty AM. Induction of apoptosis in macrophages by Pseudomonas aeruginosa azurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity. Mol Microbiol 2003; 47: 549-59; PMID:12519204; http://dx.doi.org/10.1046/j.1365-2958.2003.03317.x
  • Yamada T, Fialho AM, Punj V, Bratescu L, Das Gupta TK, Chakrabarty AM. Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity. Cell Microbiol 2005; 7: 1418-31; PMID:16153242; http://dx.doi.org/10.1111/j.1462-5822.2005.00567.x
  • Taylor BN, Mehta RR, Yamada T, Lekmine F, Christov K, Chakrabarty AM, Green A, Bratescu L, Shilkaitis A, Beattie CW, et al. Noncationic peptides obtained from azurin preferentially enter cancer cells. Cancer Res 2009; 69: 537-46; PMID:19147567; http://dx.doi.org/10.1158/0008-5472.CAN-08-2932
  • Chaudhari A, Mahfouz M, Fialho AM, Yamada T, Granja AT, Zhu Y, Hashimoto W, Schlarb-Ridley B, Cho W, Das Gupta TK, et al. Cupredoxin-cancer interrelationship: azurin binding with EphB2, interference in EphB2 tyrosine phosphorylation, and inhibition of cancer growth. Biochemistry 2007; 46: 1799-810; PMID:17249693; http://dx.doi.org/10.1021/bi061661x
  • Chrencik JE, Brooun A, Recht MI, Nicola G, Davis LK, Abagyan R, Widmer H, Pasquale EB, Kuhn P. Three-dimensional structure of the EphB2 receptor in complex with an antagonistic peptide reveals a novel mode of inhibition. J Biol Chem 2007; 282: 36505-13; PMID:17897949; http://dx.doi.org/10.1074/jbc.M706340200
  • Yamada T, Hiraoka Y, Das Gupta TK, Chakrabarty AM. Rusticyanin, a bacterial electron transfer protein, causes G1 arrest in J774 and apoptosis in human cancer cells. Cell Cycle 2004; 3: 1182-7; PMID:15467448
  • Cannon JG. Conserved lipoproteins of pathogenic neisseria species bearing the H.8 epitope: lipid-modified azurin and H.8 outer membrane protein. Clin Microbiol Rev 1989; 2: S1-4; PMID:2470496
  • Hong CS, Yamada T, Hashimoto W, Fialho AM, Das Gupta TK, Chakrabarty AM. Disrupting the entry barrier and attacking brain tumors: the role of the neisseria H.8 epitope and the Laz protein. Cell Cycle 2006; 5: 1633-41; PMID:16861907; http://dx.doi.org/10.4161/cc.5.15.2991
  • Babu MM, Priya ML, Selvan AT, Madera M, Gough J, Aravind L, Sankaran K. A database of bacterial lipoproteins (DOLOP) with functional assignments to predicted lipoproteins. J Bacteriol 2006; 188: 2761-73; PMID:16585737; http://dx.doi.org/10.1128/JB.188.8.2761-2773.2006
  • Narita S, Tokuda H. An ABC transporter mediating the membrane detachment of bacterial lipoproteins depending on their sorting signals. FEBS Lett 2006; 580: 1164-70; PMID:16288742; http://dx.doi.org/10.1016/j.febslet.2005.10.038
  • Luzzati V. Traitement statistique des erreurs dans la determination des structures cristallines. Acta Crystallogr 1952; 5: 802-10; http://dx.doi.org/10.1107/S0365110X52002161
  • Ramachandran GN, Sasisekharan V. Conformations of polypeptides and proteins. Adv Protein Chem 1968; 23: 283-438; PMID:4882249; http://dx.doi.org/10.1016/S0065-3233(08)60402-7
  • Holm L, Sander C. Protein structure comparison by alignment of distance matrices. J Mol Biol 1993; 233:123-38; PMID:8377180; http://dx.doi.org/10.1006/jmbi.1993.1489
  • Nar H, Messerschmidt A, Huber R, van de Kamp M, Canters GW. X-ray crystal structure of the two site-specific mutants His35Gln and His35Leu of azurin from Pseudomonas aeruginosa. J Mol Biol 1991; 218: 427-47; PMID:1901363; http://dx.doi.org/10.1016/0022-2836(91)90723-J
  • Nar H, Huber R, Messerschmidt A, Filippou AC, Barth M, Jaquinod M, van de Kamp M, Canters GW. Characterization and crystal structure of zinc azurin, a by-product of heterologous expression in Escherichia coli of Pseudomonas aeruginosa copper azurin. Eur J Biochem 1992; 205: 1123-9; PMID:1576995; http://dx.doi.org/10.1111/j.1432-1033.1992.tb16881.x
  • Nishikawa K. An overview on natively unfolded proteins. Seibutsu Butsuri 2009; 49: 4-10; http://dx.doi.org/10.2142/biophys.49.004
  • Wright PE, Dyson HJ. Intrinsically unstructured proteins: re-assessing the protein structure-function paradigm. J Mol Biol 1999; 293: 321-31; PMID:10550212; http://dx.doi.org/10.1006/jmbi.1999.3110
  • Daughdrill GW, Hanely LJ, Dahlquist FW. The C-terminal half of the anti-sigma factor FlgM contains a dynamic equilibrium solution structure favoring helical conformations. Biochemistry 1998; 37:1076-82; PMID:9454599; http://dx.doi.org/10.1021/bi971952t
  • Weiss MA, Ellenberger T, Wobbe CR, Lee JP, Harrison SC, Struhl K. Folding transition in the DNA-binding domain of GCN4 on specific binding to DNA. Nature 1990; 347:575-8; PMID:2145515; http://dx.doi.org/10.1038/347575a0
  • Xue B, Dunbrack RL, Williams RW, Dunker AK, Uversky VN. PONDR-FIT: a meta-predictor of intrinsically disordered amino acids. Biochim Biophys Acta 2010; 1804: 996-1010; PMID:20100603; http://dx.doi.org/10.1016/j.bbapap.2010.01.011
  • Ward JJ, Sodhi JS, McGuffin LJ, Buxton BF, Jones DT. Prediction and functional analysis of native disorder in proteins from the three kingdoms of life. J Mol Biol 2004; 337: 635-45; PMID:15019783; http://dx.doi.org/10.1016/j.jmb.2004.02.002
  • Linding R, Jensen LJ, Diella F, Bork P, Gibson TJ, Russell RB. Protein disorder prediction: implications for structural proteomics. Structure 2003; 11: 1453-9; PMID:14604535; http://dx.doi.org/10.1016/j.str.2003.10.002
  • Hong CS, Yamada T, Fialho AM, Das Gupta TK, Chakrabarty AM. Transport agents for crossing the blood-brain barrier and into brain cancer cells, and methods of use thereof. US patent 2010; 7807183
  • Dutta Ray T, Lewis LA, Gulati S, Rice PA, Ram S. Novel blocking human IgG directed against the pentapeptide repeat motifs of Neisseria meningitides Lip/H.8 and Laz lipoproteins. J Immunol 2011; 186: 4881-94; PMID:21402895; http://dx.doi.org/10.4049/jimmunol.1003623
  • Chaudhari A, Fialho AM, Ratner D, Gupta P, Hong CS, Kahali S, Yamada T, Haldar K, Murphy S, Cho W, et al. Azurin, Plasmodium falciparum malaria and HIV/AIDS: inhibition of parasitic and viral growth by azurin. Cell Cycle 2006; 5: 1642-8; PMID:16861897; http://dx.doi.org/10.4161/cc.5.15.2992
  • Naguleswaran A, Fialho AM, Chaudhari A, Hong CS, Chakrabarty AM, Sullivan WJ, Jr. Azurin-like protein blocks invasion of Toxoplasma gondii through potential interactions with parasite surface antigen SAG1. Antimicrob Agents Chemother 2008; 52: 402-8; PMID:18070964; http://dx.doi.org/10.1128/AAC.01005-07
  • Warso MA, Richards JM, Mehta D, Christov K, Schaeffer C, Rae Bressler L, Yamada T, Majumdar D, Kennedy SA, Beattie CW, et al. A first-in-class, first-in-human phase I trial of p28, a non-HDM2-mediated peptide inhibitor of p53 ubiquitination in patients with advanced solid tumours. Br J Cancer 2013; 108: 2061-70; PMID:23449360; http://dx.doi.org/10.1038/bjc.2013.74
  • Sambrook J, Fritsch EF, Maniatis T. Molecular cloning. A Laboratory Manual, second ed., Taylor & Francis Harbor, NY. 1989.
  • Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227: 680-5; PMID:5432063; http://dx.doi.org/10.1038/227680a0
  • Otwinoski Z, Minor W. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol 1997; 276: 307-26; http://dx.doi.org/10.1016/S0076-6879(97)76066-X
  • Vagin A, Teplyakov A. Molecular replacement with MOLREP. Acta Crystallogr Sect D Biol Crystallogr 2010; 66: 22-5; PMID:20057045; http://dx.doi.org/10.1107/S0907444909042589
  • Collaborative Computational Project. The CCP4 suite: programs for protein crystallography. Acta Crystallogr Sect D Biol Crystallogr 1994; 50: 760-3; PMID:15299374; http://dx.doi.org/10.1107/S0907444994003112
  • Emsley P, Cowtan K. Coot: model-building tools for molecular graphics. Acta Crystallogr Sect D Biol Crystallogr 2004; 60: 2126-32; PMID:15572765; http://dx.doi.org/10.1107/S0907444904019158
  • Murshudov GN, Vagin AA, Dodson EJ. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr Sect D Biol Crystallogr 1997; 53: 240-55; PMID:15299926; http://dx.doi.org/10.1107/S0907444996012255
  • Kabsch W. A solution for the best rotation to relate two sets of vectors. Acta Crystallogr Sect A 1976; 32: 922-3; http://dx.doi.org/10.1107/S0567739476001873
  • Laskowski RA, MacArthur MW, Moss DS, Thornton JM. PROCHECK: a program to check the stereochemical quality of protein structures. J Appl Crystallogr 1993; 26: 283-91; http://dx.doi.org/10.1107/S0021889892009944
  • DeLano WL. The PyMOL Molecular Graphics System. Taylor & Francis, San Carlos, CA. 2004
  • Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The protein data bank. Nucleic Acids Res 2000; 28: 235-42; PMID:10592235; http://dx.doi.org/10.1093/nar/28.1.235

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.